anmelden
SMI Expanded
1.836,04
PKT
+19,30
PKT
+1,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.04.05 | Swiss Prime Site Neutral | Sarasin Research | |
| 18.04.05 | Roche Outperform | HypoVereinsbank | |
| 18.04.05 | Nestlé Neutral | Sarasin Research | |
| 18.04.05 | Roche Buy | Sarasin Research | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Galenica Market Perform | Vontobel | |
| 14.04.05 | Roche Halten | Helaba Trust | |
| 15.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 15.04.05 | Roche Buy | SES Research | |
| 14.04.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
| 13.04.05 | Lonza Reduce | Sarasin Research | |
| 13.04.05 | Novartis Neutral | Sarasin Research | |
| 13.04.05 | Logitech Neutral | Sarasin Research | |
| 12.04.05 | Adecco SA Sell | Dresdner Kleinwort Wasserstein | |
| 11.04.05 | Lonza Overweight | JP Morgan | |
| 11.04.05 | Richemont Buy | Sarasin Research | |
| 11.04.05 | Adecco SA Accumulate | Helvea | |
| 11.04.05 | Richemont Accumulate | Helvea | |
| 11.04.05 | Givaudan Equal weight | Lehman Brothers | |
| 11.04.05 | Zurich Insurance Neutral | JP Morgan | |
| 11.04.05 | Givaudan Neutral | Helvea | |
| 11.04.05 | Barry Callebaut Neutral | Helvea | |
| 11.04.05 | Givaudan Underperform | HypoVereinsbank | |
| 11.04.05 | Swiss Life Akkumulieren | Nord LB | |
| 11.04.05 | Givaudan Neutral | Sarasin Research | |
| 08.04.05 | Novartis Accumulate | Helvea | |
| 08.04.05 | Zurich Insurance Accumulate | Helvea | |
| 08.04.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 08.04.05 | Givaudan Neutral | Helvea | |
| 08.04.05 | Zurich Insurance Sector Outperform | Vontobel | |
| 08.04.05 | Swiss Life Neutral | HypoVereinsbank | |
| 08.04.05 | Zurich Insurance Hold | Dresdner Kleinwort Wasserstein | |
| 12.04.05 | Swiss Life Kaufen | M.M. Warburg | |
| 07.04.05 | Lonza Reduce | Sarasin Research | |
| 07.04.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 08.04.05 | Swiss Prime Site Neutral | Sarasin Research | |
| 07.04.05 | Swiss Life Sell | Merck Finck & Co | |
| 08.04.05 | Helvetia Baloise Neutral | Sal. Oppenheim | |
| 07.04.05 | Swiss Life Buy | M.M. Warburg |